InsidersTradesSigma
Discover the complete record of transactions filed by LEE BYOUNG CHUL, Chief Executive Officer. Insider active across 2 companies, notably 카나프테라퓨틱스. Cumulatively, 2 reports have been logged. Regulator: DART (FSS). The full history is openly available.
2 of 2 declarations
LEE BYOUNG CHUL is the CEO of 카나프테라퓨틱스, a company specializing in biotechnology. He is responsible for the overall strategy and product development. LEE BYOUNG CHUL is committed to positioning the company as a leader in innovative therapies.